
Management ChangeJul 24, 2026, 05:01 PM
Pediatrix Medical Group Appoints David Haddock as GC; Mary Ann Moore Departs
AI Summary
Pediatrix Medical Group, Inc. announced a leadership transition in its legal and administrative departments. Ms. Mary Ann E. Moore, Executive Vice President, General Counsel, Chief Administrative Officer, and Secretary, will transition from her role, serving in an advisory capacity until October 31, 2026. Her departure is classified as a termination without cause, entitling her to benefits outlined in her employment agreement. Concurrently, the company has appointed Mr. David Haddock as the new Executive Vice President, General Counsel, and Secretary.
Key Highlights
- Ms. Mary Ann E. Moore will transition from her role as Executive Vice President, General Counsel, Chief Administrative Officer, and Secretary.
- Ms. Moore will serve in an advisory role until October 31, 2026, and her transition is effective as of that date.
- Her departure is considered a termination without cause, entitling her to specified benefits.
- Mr. David Haddock has been appointed as the new Executive Vice President, General Counsel, and Secretary.
Price Impact
More from MD